PHNO, a novel dopamine agonist, in anima
β
Dr. William Koller; Gregory Herbster; John Gordon
π
Article
π
1987
π
John Wiley and Sons
π
English
β 347 KB
PHNO, a naphthoxazine compound, was investigated in animal models of central dopaminergic activity. The drug in doses of 5-300 micrograms/kg when administered subcutaneously, or transdermally, induced stereotypic behavior in rats which was blocked by haloperidol but not by reserpine pretreatment. In